Sarepta Therapeutics Inc (SRPT)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	-267,824	-536,201	-459,710	-564,163	-705,563
Total assets	US$ in thousands	3,264,580	3,128,370	3,147,970	2,984,720	1,822,820
Operating ROA		-8.20%	-17.14%	-14.60%	-18.90%	-38.71%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $-267,824K ÷ $3,264,580K
= -8.20%

Sarepta Therapeutics Inc's operating return on assets (operating ROA) has shown a fluctuating trend over the past five years. The operating ROA was -8.20% in 2023, representing an improvement from the previous year. However, the company's performance in 2023 is still below the industry average.

In 2022, Sarepta Therapeutics recorded an operating ROA of -17.14%, showing a significant decline from 2021. This indicates operational inefficiencies or decreased profitability during that period.

The company's operating ROA was -14.60% in 2021, reflecting a slight decrease compared to 2020. Although the trend shows a marginal improvement from the prior year, Sarepta Therapeutics' returns remain in the negative territory.

In 2020, the operating ROA was at its lowest point at -18.90%, indicating that the company faced challenges in generating operating profits relative to its asset base.

The most significant decline was seen in 2019, with an operating ROA of -38.71%. This suggests that Sarepta Therapeutics struggled to effectively utilize its assets to generate operating profits during that period.

Overall, the analysis of Sarepta Therapeutics Inc's operating ROA indicates a mixed performance over the past five years, with fluctuations in profitability and operational efficiency. It is crucial for the company to focus on improving its operational performance and optimizing asset utilization to enhance its financial health and competitiveness in the industry.